Literature DB >> 3661590

Role of clindamycin in the treatment of central nervous system toxoplasmosis.

K V Rolston1, J Hoy.   

Abstract

Three patients with acquired immune deficiency syndrome (AIDS), central nervous system toxoplasmosis, and hypersensitivity to sulfadiazine were given treatment with clindamycin plus pyrimethamine. All three showed improvement clinically with resolution of symptoms. Two patients had computed tomographic evidence of improvement with reduction in size or clearing of cerebral lesions and the third had resolution of chorioretinitis. Another patient who had a relapse during administration of standard therapy (pyrimethamine plus sulfadiazine) had a clinical response when clindamycin was added to this regimen. Clindamycin in combination with pyrimethamine, or as an adjunct to standard therapy, may be useful in the treatment of central nervous system toxoplasmosis in patients with AIDS.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3661590     DOI: 10.1016/0002-9343(87)90769-8

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  11 in total

1.  Opportunistic infections in HIV-infected patients.

Authors:  S D Shafran
Journal:  Can J Infect Dis       Date:  1992-03

2.  Evaluation of the efficacy and safety of clindamycin plus pyrimethamine for induction and maintenance therapy of toxoplasmic encephalitis in AIDS.

Authors:  C Katlama
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-03       Impact factor: 3.267

3.  A retrospective study of primary and maintenance therapy of toxoplasmic encephalitis with oral clindamycin and pyrimethamine.

Authors:  C U Foppa; T Bini; G Gregis; A Lazzarin; R Esposito; M Moroni
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-03       Impact factor: 3.267

4.  Effect of clindamycin on pneumonia from reactivation of Toxoplasma gondii infection in mice.

Authors:  G A Filice; C Pomeroy
Journal:  Antimicrob Agents Chemother       Date:  1991-04       Impact factor: 5.191

5.  Clindamycin therapy of experimental meningitis caused by penicillin- and cephalosporin-resistant Streptococcus pneumoniae.

Authors:  M M París; S Shelton; M Trujillo; S M Hickey; G H McCracken
Journal:  Antimicrob Agents Chemother       Date:  1996-01       Impact factor: 5.191

6.  Ocular toxoplasmosis in AIDS patients.

Authors:  D J Gagliuso; S A Teich; A H Friedman; J Orellana
Journal:  Trans Am Ophthalmol Soc       Date:  1990

Review 7.  Therapy and prophylaxis of systemic protozoan infections.

Authors:  W C Van Voorhis
Journal:  Drugs       Date:  1990-08       Impact factor: 9.546

8.  Comparison of two medications in central nervous system toxoplasmosis in patients with AIDS.

Authors:  A Antinori; A Ammassari; G Maiuro; G Camilli; F Damiano; G Federico; E Pizzigallo; E Tamburrini
Journal:  Ital J Neurol Sci       Date:  1992-09

Review 9.  Current recommendations and future prospects in the treatment of toxoplasmosis.

Authors:  R E McCabe; S Oster
Journal:  Drugs       Date:  1989-12       Impact factor: 9.546

10.  Comparative study of bioavailabilities and pharmacokinetics of clindamycin in healthy volunteers and patients with AIDS.

Authors:  G Gatti; J Flaherty; J Bubp; J White; M Borin; J Gambertoglio
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.